News
Allison Stange lost 40 pounds since starting Zepbound in April 2024, improving both her blood pressure and sleep apnea. Now ...
Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.
Zepbound (tirzepatide) is a prescription drug that’s used for weight loss and obstructive sleep apnea in certain adults. Zepbound comes as a liquid solution inside prefilled injection pens.
Sleep apnea could be costing you brain power and increasing your risk of dementia and Alzheimer's disease, a new study says.
There is a need to identify patients with obstructive sleep apnea after a weight-loss drug was approved for treatment of the ...
The Food and Drug Administration (FDA) has approved Zepbound to help treat obstructive sleep apnea (OSA) in people with obesity. The drug also has FDA approval as a weight loss and weight ...
while Zepbound is approved for weight loss in adults with a BMI of 30 or higher if they have a related condition like high blood pressure, high cholesterol, Type 2 diabetes, sleep apnea or heart ...
In a major clinical trial, the weight loss drug Wegovy has been able to treat a serious form of liver disease in the majority ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results